Vanguard Group Inc Biomerica Inc Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Biomerica Inc stock. As of the latest transaction made, Vanguard Group Inc holds 609,365 shares of BMRA stock, worth $268,120. This represents 0.0% of its overall portfolio holdings.
Number of Shares
609,365
Previous 609,365
-0.0%
Holding current value
$268,120
Previous $761,000
33.64%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BMRA
# of Institutions
42Shares Held
3.92MCall Options Held
800Put Options Held
100-
Granahan Investment Management, LLC Waltham, MA1.13MShares$496,9890.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT953KShares$419,4360.0% of portfolio
-
Russell Investments Group, Ltd.225KShares$99,1910.0% of portfolio
-
Potomac Capital Management, Inc.168KShares$73,7880.37% of portfolio
-
Black Rock Inc. New York, NY149KShares$65,5950.0% of portfolio
About BIOMERICA INC
- Ticker BMRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 13,427,700
- Market Cap $5.91M
- Description
- Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...